Giulianotti Pier Cristoforo, Bustos Roberto, Valle Valentina, Aguiluz Gabriela, Pavelko Yevhen, Fernandes Eduardo
Division of General, Minimally Invasive and Robotic Surgery, Department of Surgery, University of Illinois at Chicago, 840 S. Wood Street, Suite 435E (MC 958), Chicago, IL, 60612, USA.
Division of General, Minimally Invasive and Robotic Surgery, Department of Surgery, University of Illinois at Chicago, 840 S. Wood Street, Suite 435E (MC 958), Chicago, IL, 60612, USA.
Int J Surg Case Rep. 2019;60:244-248. doi: 10.1016/j.ijscr.2019.06.033. Epub 2019 Jun 21.
Liver hemangiomas are benign liver lesions that require surgical excision when large and symptomatic. Often, these tumors are removed through large anatomical resections which sacrifice more liver parenchyma than needed. Tumor enucleation, which takes advantage of a digitoclasia-like technique along the plane between the tumor pseudo-capsule and liver parenchyma, poses challenges when performed laparoscopically. We propose a parenchymal sparing, minimally invasive, robotic-assisted technique to remove liver hemangiomas.
Three male patients with symptomatic hemangiomas were treated in our center between 2015 and 2018. The lesions were located in segment II, III and segment IV-V respectively. Robotic-assisted hemangioma enucleation was accomplished successfully in all three patients. The procedures were performed with a parenchyma-sparing intent and a formal segmentectomy was not required. There were no conversions to open surgery.
The robotic platform provides a powerful tool in the enucleation of liver hemangiomas. The enhanced vision and the superior suturing ability allow to develop safely the plane between the tumor pseudo-capsule and the liver parenchyma, with outstanding selective control of all the vascular supply and drainage encountered during the dissection. Furthermore, precision of the hilar dissection allows selective lobar or sectorial arterial control which helps minimize intraoperative bleeding.
In our experience, robot-assisted enucleation of liver hemangiomas offers low morbidity, fast recovery, excellent cosmetic results, and it could become a therapeutic option when the location of the hemangioma allows this approach.
肝血管瘤是良性肝脏病变,当瘤体较大且有症状时需要手术切除。通常,这些肿瘤通过大范围的解剖性切除来移除,这牺牲了比所需更多的肝实质。肿瘤剜除术利用类似手指捏碎的技术沿着肿瘤假包膜与肝实质之间的平面进行,但在腹腔镜下实施时具有挑战性。我们提出一种保留实质、微创、机器人辅助的技术来切除肝血管瘤。
2015年至2018年间,我们中心治疗了3例有症状的血管瘤男性患者。病变分别位于肝段II、III以及肝段IV-V。所有3例患者均成功完成了机器人辅助的血管瘤剜除术。手术以保留实质为目的进行,无需进行正规的肝段切除术。无一例转为开放手术。
机器人平台为肝血管瘤剜除术提供了强大工具。增强的视野和卓越的缝合能力使我们能够安全地在肿瘤假包膜与肝实质之间拓展平面,在解剖过程中对所有遇到的血管供应和引流进行出色的选择性控制。此外,肝门解剖的精确性允许选择性地控制叶或段动脉,这有助于减少术中出血。
根据我们的经验,机器人辅助的肝血管瘤剜除术具有低发病率、恢复快、美容效果好等优点,当血管瘤的位置允许采用这种方法时,它可能成为一种治疗选择。